The global knee hyaluronic acid injections market generated USD 2.09 billion in revenue in 2023, and is projected to grow to USD 3.40 billion by 2033, reflecting a CAGR of 5% over the forecast period. As an effective minimally invasive treatment for knee osteoarthritis and joint pain, knee hyaluronic acid injections are gaining traction among patients seeking relief without the need for invasive surgical procedures. The market’s growth is fueled by the rising awareness of these treatment options, increased healthcare management programs, and the growing preference for non-surgical alternatives in managing chronic joint pain.
The expanding use of knee hyaluronic acid injections is also supported by advancements in medical technology and the development of novel product lines that offer enhanced effectiveness, safety, and patient comfort. Research and development in the field have led to the introduction of advanced formulations, longer-lasting injections, and improved delivery systems, which are expected to further boost market growth. As technological investments continue to improve the precision and outcomes of treatments, patients are more likely to opt for knee injections as a viable alternative to traditional surgical interventions.
Additionally, the increasing prevalence of knee osteoarthritis and the rising global geriatric population are contributing to the demand for knee hyaluronic acid injections. As more individuals seek relief from pain and stiffness caused by joint degeneration, the market for these injections is anticipated to expand. The growing adoption of minimally invasive therapies, which offer quicker recovery times and reduced risk of complications, is another key factor driving the growth of this market.
Key Takeaways:
- The knee hyaluronic acid injections market is projected to grow from USD 2.09 billion in 2023 to USD 3.40 billion by 2033, at a CAGR of 5%.
- Rising awareness, the increasing demand for minimally invasive treatments, and growing healthcare programs are driving market growth.
- Technological advancements in injection formulations and delivery systems are expected to accelerate market sales.
- The growing prevalence of knee osteoarthritis and the aging population are key contributors to market expansion.
Key Growth Drivers
- Increasing Awareness and Demand for Healthcare Management: There is a growing focus on healthcare management programs, which is driving the demand for minimally invasive treatment options like hyaluronic acid injections.
- Technological Advancements: Ongoing investments in technology and the introduction of novel product lines are expected to enhance sales and improve treatment outcomes.
- Rising Prevalence of Osteoarthritis: The increasing incidence of knee osteoarthritis, particularly among the aging population, is propelling the demand for effective pain management solutions.
Competitive Landscape
Manufacturers of knee hyaluronic acid injections aim to carry out strategic expansions through mergers and acquisitions, Product Out- Licensing, and exclusive distribution to consolidate growth in a competitive market.
The market is highly competitive by the present key players globally. These players are developing unique and innovative products to attract consumers’ requirements. These players focus on consumers’ desires and offer improved products.
The key players are adopting strategies to upsurge the global market are mergers, acquisitions, partnerships, collaborations, and product launches. They continue to fuel the global market through their innovations and invest huge amounts in research and development activities. These players are reaching more audiences by attending seminars, exhibitions, and trade shows.
Other Essential Players in the Global Market are:
- Sanofi
- Anika Therapeutics Inc. (DePuy Synthes Inc.)
- Seikagaku Corporation
- Zimmer Biomet
- Institut Biochimique SA (Bioventus LLC)
- Fidia Farmaceutici S.p.A
- Meiji Seika Pharma Co. Ltd. (OrthogenRx)
- Ferring B.V.
- Viatrus Inc.
- Hanmi Pharm Co. Ltd. (Teva Pharmaceuticals Industries Ltd.)
- Chugai Pharmaceuticals Co. Ltd.
- Haohai Biological Technology
- Hunan Jingfeng Pharmaceutical Co. Ltd.
- SciViscion Biotech Inc. (MACO PHARMA S.A.S)
- BioPolymer GmbH & Co. KG
- TRB Chemedica International SA
- MDT Int’l S. A.
Recent Developments in the Global Market are:
In May 2021, Ono and Seikagaku announced a manufacturing and marketing approval in Japan for JOYCLU® 30mg intra-articular injection, a joint function improvement agent, for the indication of osteoarthritis (Knee Joint and Hip Joint).
Seikagaku also entered into exclusive marketing and distribution agreements in all commercialized markets with leading players such as Zimmer Biomet (USA), MDM S.p.A. (Italy), Kaken Pharmaceutical Co. (Japan), and Kunming Baker Norton Pharmaceutical Co. Ltd. (China).
Get the Comprehensive Full Report Now
Knee Hyaluronic Acid Injections Market by Category
By Product:
- Single Injection Knee Hyaluronic Acid Injections
- Three Injection Knee Hyaluronic Acid Injections
- Five Injection Knee Hyaluronic Acid Injections
- Next Generation (Steroid Combination)
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Orthopaedics Clinics
- Retail Pharmacies
- Online Sales
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East and Africa
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
